Indeed, Gαi3 shRNA or KO led to enhanced activation of PKA and the Hippo pathway kinase LATS1/2, coupled with the inactivation of YAP/TAZ in primary pancreatic cancer cells. The gene discussed is YAP1; the disease is familial pancreatic carcinoma.